oral glp 1 weight loss Lilly orforglipron GLP-1 phase 3 trial With FDA approval of Wegovy
Description
Once the primary visceral (intra-abdominal) fat depots are saturated, free fatty acid spillover into non-adipose tissues and begin to accumulate in ectopic fat depots (liver, skeletal muscle, heart, pancreas, kidney, bone marrow, and central nervous system (CNS) which leads to lipotoxicity, inflammation, and ultimately B-cell dysfunction [64,65,66,67,68,69,70,71]
Receive the latest news and breaking updates, straight from our newsroom to your inbox.
They also interact with food choices
(August 2023)
In either case, patients should be closely monitored for both efficacy and adverse effects
Dinner (27 Grams of Protein) Apple and Brie Stuffed Chicken Breast (Haute and Healthy Living)
